CAIRN THERAPEUTICS
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies. While tremendous advances have been made in the fight against cancer over the last two decades, it has not been enough. Too many people, young and old, still lose their battle with cancer, and those who survive often experience debilitating side effects from the drugs used to treat them. Our passion to make a positive difference in this regard is embodied in CT-262, the first in a new class of DNA binding agents that has the potential to revolutionize the use of chemotherapy.
CAIRN THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.cairntherapeutics.com
Status:
Active
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apache ReCAPTCHA Microsoft Azure DNS AJAX Libraries API GoDaddy DNS
Current Employees Featured
Diarmuid Boran CEO & Co-Founder @ Cairn Therapeutics
CEO & Co-Founder
Founder
Official Site Inspections
http://www.cairntherapeutics.com
- Host name: 29.0.153.160.host.secureserver.net
- IP address: 160.153.0.29
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Cairn Therapeutics"
About Cairn Therapeutics
Cairn Therapeutics’ lead candidate, CT-262, was invented by Dale Boger, Ph.D. at Scripps Research. Dr. Boger is considered the premier researcher of duocarmycin drugs.See details»
Cairn Therapeutics Announces New Management Team and Board …
Dec 18, 2023 Company Intends to Initiate First-in-Human Clinical Trials in Cancer Next Year WILMINGTON, DE – Cairn Therapeutics, Inc., a pharmaceutical company developing new, …See details»
Cairn Therapeutics - Crunchbase Company Profile & Funding
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies. While tremendous advances have been made in the fight against cancer …See details»
Cairn Therapeutics - LinkedIn
Cairn Therapeutics, Inc. is a pharmaceutical company with a mission to help patients beat cancer. Founded in 2016, Cairn is developing its lead candidate, CT-262, a first-in-its-class treatment ...See details»
CAIRN THERAPEUTICS LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CAIRN THERAPEUTICS LLC of Lawrence, KS. Get the latest business insights from Dun & Bradstreet.See details»
Cairn Therapeutics - Products, Competitors, Financials, Employees ...
Cairntherapeutics.com. Overview & Products; Financials; People; Founded Year 2016. Stage Seed | Alive. Total Raised $3M. Last Raised $3M | 4 yrs ago. About Cairn Therapeutics. Cairn …See details»
Cairn Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Cairn Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Cairn Therapeutics - PitchBook
Cairn Therapeutics General Information Description. Operator of a pharmaceutical company intended to help patients beat cancer. The company's drugs help to reduce the debilitating …See details»
Cairn Therapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Explore Cairn Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
Cairn Therapeutics Inc - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Cairn Therapeutics Announces New Management Team and Board …
Dec 18, 2023 Company Intends to Initiate First-in-Human Oncology Clinical Trials Next YearWILMINGTON, DE, US, December 18, 2023 /E...See details»
Cairn Therapeutics Announces New Management Team and Board …
Dec 21, 2023 W. Scott Evangelista, who previously served as Executive Chairman at Cairn, is now taking the helm as CEO and Chief Financial Officer. In his new role, Evangelista will lead …See details»
Bringing you the latest news on healthcare and wellness
Sutton@cairntherapeutics.com. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the …See details»
More Impact | Varian
Over the next few months, our corporate identity will transition to Siemens Healthineers, with the transition complete by early 2026. That means the name, logo, and visual identity of Siemens …See details»
Cairn Therapeutics Completes $4M Bridge Investment Round to …
Oct 28, 2024 WILMINGTON, DE Cairn Therapeutics, Inc., (“Cairn” or the “Company”), a pharmaceutical company developing highly targeted medications for the treatment of cancer, …See details»
Cairn Therapeutics Announces New Management Team and Board …
Dec 18, 2023 EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes …See details»
Press Releases- Cairn Therapeutics
Dec 18, 2023 Company Intends to Initiate First-in-Human Clinical Trials in Cancer Next Year WILMINGTON, DE – Cairn Therapeutics, Inc., a pharmaceutical company developing new, …See details»
Cairn Therapeutics Completes $4M Bridge Investment Round to …
Oct 29, 2024 Cairn intends to file an IND and begin First-in-Human trials next year. For more information, visit www.cairntherapeutics.com. Sutton Faller Cairn Therapeutics, Inc. +1 610 …See details»
Cairn Therapeutics to Present at MedInvest Biotech & Pharma …
Mar 28, 2024 Cairn Therapeutics, Inc., (“Cairn” or the “Company”), a pharmaceutical company developing highly targeted medications for the treatment of cancer, todaySee details»
Cairn Therapeutics Announces New Management Team and Board …
Dec 19, 2023 Cairn Therapeutics Announces New Management Team and Board of DirectorsSee details»